Network Meta-Analysis of Efficacy and Safety of Chemotherapy and Target Therapy in the First-Line Setting of Advanced Pancreatic Cancer

Network Meta-Analysis of Efficacy and Safety of Chemotherapy and Target Therapy in the First-Line Setting of Advanced Pancreatic Cancer

Both gemcitabine and fluoropyrimidine are recommended backbones in the first-line treatment of pancreatic ductal adenocarcinoma (PDAC). To compare the efficacy and safety of these two therapeutic backbones, and to investigate the optimal therapies, we conducted a network meta-analysis. By retrospect...

Full description

Bibliographic Details
Main Authors: Kun-I Lin, Jia-Lian Yang, Yu-Chao Lin, Che-Yi Chou, Jin-Hua Chen, Chin-Chuan Hung
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Series:Cancers
Subjects:
advanced pancreatic cancer
target therapy
chemotherapy
efficacy outcomes
adverse effects
Online Access:https://www.mdpi.com/2072-6694/11/11/1746

Internet

https://www.mdpi.com/2072-6694/11/11/1746

Similar Items